Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Donanemab: Appropriate use recommendations.

The journal of prevention of Alzheimer's disease·2025
Same author

Reducing the lipase LIPE in mutant α-synuclein mice improves Parkinson-like deficits and reveals sex differences in fatty acid metabolism.

Neurobiology of disease·2024
Same author

Editorial: A Is for Amyloid.

The journal of prevention of Alzheimer's disease·2020
Same author

The Future of Anti-Amyloid Trials.

The journal of prevention of Alzheimer's disease·2020
Same author

Embryonic mosaic deletion of APP results in displaced Reelin-expressing cells in the cerebral cortex.

Developmental biology·2017
Same author

Discovery of notch-sparing gamma-secretase inhibitors.

Current Alzheimer research·2010

Related Experiment Video

Updated: Mar 9, 2026

Detection of Protease Activity by Fluorescent Peptide Zymography
09:56

Detection of Protease Activity by Fluorescent Peptide Zymography

Published on: January 20, 2019

13.7K

Enzymatic Assays for Studying Intramembrane Proteolysis.

D M Bolduc1, D J Selkoe1, M S Wolfe1

  • 1Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.

Methods in Enzymology
|January 10, 2017
PubMed
Summary

Intramembrane-cleaving proteases (I-CLiPs) are crucial enzymes involved in cell signaling and disease. Developing in vitro assays for these membrane-bound proteases, like gamma-secretase, aids therapeutic development.

Keywords:
AmyloidAssayMembraneProteaseProtein complex

More Related Videos

Use of Recombinant Fusion Proteins in a Fluorescent Protease Assay Platform and Their In-gel Renaturation
19:23

Use of Recombinant Fusion Proteins in a Fluorescent Protease Assay Platform and Their In-gel Renaturation

Published on: January 16, 2019

9.8K
Evaluation of Protein–Protein Interactions using an On-Membrane Digestion Technique
07:07

Evaluation of Protein–Protein Interactions using an On-Membrane Digestion Technique

Published on: July 19, 2019

7.2K

Related Experiment Videos

Last Updated: Mar 9, 2026

Detection of Protease Activity by Fluorescent Peptide Zymography
09:56

Detection of Protease Activity by Fluorescent Peptide Zymography

Published on: January 20, 2019

13.7K
Use of Recombinant Fusion Proteins in a Fluorescent Protease Assay Platform and Their In-gel Renaturation
19:23

Use of Recombinant Fusion Proteins in a Fluorescent Protease Assay Platform and Their In-gel Renaturation

Published on: January 16, 2019

9.8K
Evaluation of Protein–Protein Interactions using an On-Membrane Digestion Technique
07:07

Evaluation of Protein–Protein Interactions using an On-Membrane Digestion Technique

Published on: July 19, 2019

7.2K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Enzymology

Background:

  • Proteolysis within cellular membranes is mediated by intramembrane-cleaving proteases (I-CLiPs).
  • I-CLiPs hydrolyze transmembrane domains of proteins, regulating essential signaling pathways.
  • Dysfunction of I-CLiPs is implicated in diseases such as Alzheimer's, Parkinson's, cancer, and pathogen virulence.

Purpose of the Study:

  • To describe in vitro enzymatic assays for studying I-CLiPs, focusing on the Alzheimer's disease-associated gamma-secretase.
  • To provide tools for understanding the complex catalytic mechanisms of I-CLiPs.
  • To facilitate the development of therapeutic strategies targeting I-CLiPs.

Main Methods:

  • Development and application of in vitro enzymatic assays for membrane-bound proteases.
  • Utilizing assays to study the gamma-secretase protease involved in Alzheimer's disease.
  • Adapting assays for broader application to other I-CLiPs.

Main Results:

  • Successful development of in vitro assays for studying gamma-secretase activity.
  • These assays have aided in the development of gamma-secretase-targeting therapeutic compounds.
  • The assays provide mechanistic insights into the function of various I-CLiPs.

Conclusions:

  • In vitro assays are essential for dissecting the mechanisms of membrane-embedded proteases.
  • These assays are valuable tools for understanding I-CLiPs and developing treatments for associated diseases.
  • Further research into I-CLiP mechanisms can unlock new therapeutic avenues.